The leading assignee in this dataset holds 44 of the 1,243 records in scope, with the top 5 assignees combined accounting for 13.8% of all records and the top 10 reaching 22.1%. That means no single company controls the field; instead there is a modest leader followed by a long tail of assignees with far fewer filings each. The ranking spans 100 assignees drawn from instrumentation, diagnostics and pharmaceutical manufacturing backgrounds, so leadership varies depending on whether you weight by raw filing count or by recent-year activity.

Filings rose from 52 records in 2017 to a peak of 90 in 2022, then eased to 52 records by 2024, a 26% decline over that three-year span. However, 2025 and 2026 figures are still incomplete because publication typically lags actual filing by around 18 months, so those most recent years understate real activity rather than confirming a continued drop. The more defensible read is that 2022 was a high point and the field has settled to a somewhat lower but still active filing rate.

Almost the entire corpus, 99.4% of the 1,243 records, carries the G01N material analysis and testing classification, with G01J radiation and light measurement present in 29.4%. Life-science-adjacent classes appear at meaningfully lower but still notable rates: A61B diagnosis and surgery at 13.6%, C12Q enzyme/DNA measurement at 6.3%, and C12M bioreactor apparatus at 3.4%. AI-based computation under G06N appears in only 3.8% of records, indicating the software side of calibration modelling is comparatively lightly claimed against the optical hardware base.